Valeant Pharma (VRX) option implied volatility elevated into Q1 and outlook

Valeant Pharma (NYSE: VRX) May weekly call option implied volatility is at 117, May is at 80, June is at 55; compared to its 52-week range of 41 to 87 into the expected release of Q1 results before the open on May 8.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Accenture (ACN) spreader of 22700 contracts of August 120 puts and 22200 contracts of August 130 calls as share price down 7.2%
• Amazon (AMZN) call put ratio 2.2 calls to 1 put